BusinessNews

Mankind Pharma to Raise ₹9,000 Crore for Bharat Serums Acquisition, Eyeing Market Leadership in Gynaecology-Fertility

Mankind Pharma Ltd, the fourth-largest pharmaceutical company in India, is gearing up to raise over ₹9,000 crore through a combination of non-convertible debentures (NCDs) and short-term commercial paper. This move is part of the company’s strategy to support its ₹13,630 crore acquisition of Bharat Serums and Vaccines Ltd (BSV), a deal first announced in late July. The company anticipates an…
Read more
BusinessNews

Kalpataru Plans ₹1,590 Crore IPO to Repay Debt and Support Growth

Real estate developer Kalpataru has announced plans to raise up to ₹1,590 crore through an initial public offering (IPO). The funds will primarily be used to repay existing loans, with the remainder allocated for general corporate purposes. This IPO will be a fresh issue of shares. The Mumbai-based company has a robust portfolio, having completed 70 projects across major cities such as Mumbai…
Read more
BusinessNews

Vedanta Board Greenlights Sale of 2.6% Stake in Hindustan Zinc to Raise ₹6,450 Crore

In a notable development, Vedanta Ltd, under the leadership of Anil Agarwal, has received approval from its board to proceed with an Offer For Sale (OFS) of its 2.6% stake in Hindustan Zinc (HZL). The board’s decision authorizes the sale of up to 110 million equity shares of Hindustan Zinc, a move that is set to raise approximately ₹6,450 crore at the current share price of ₹586.00 on the…
Read more
BusinessNews

Coca-Cola Beats Earnings Expectations, Raises Full-Year Outlook on Global Demand Surge

Coca-Cola exceeded earnings expectations for the second quarter and has raised its full-year outlook amid robust global demand for its beverages. The company now anticipates organic revenue growth of 9% to 10% for 2024, up from a previous forecast of 8% to 9%. Additionally, Coca-Cola has adjusted its comparable earnings growth projection to a range of 5% to 6%, compared to the earlier forecast of…
Read more